Graham Capital Management, L.P. Moderna, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 9,117 shares of MRNA stock, worth $458,493. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,117
Previous 3,391
168.86%
Holding current value
$458,493
Previous $361,000
199.72%
% of portfolio
0.03%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
1,022Shares Held
242MCall Options Held
9.07MPut Options Held
13.1M-
Baillie Gifford & CO42.5MShares$2.14 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$1.99 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.29 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$756 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$363 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $19.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...